Skip to content

Influence of Hyperbaric Oxygen Therapy on Sensorimotor Functions in Diabetic Peripheral Neuropathy

Influence of Hyperbaric Oxygen Therapy on Sensorimotor Functions in Diabetic Peripheral Neuropathy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202101805407126
Enrollment
40
Registered
2021-01-12
Start date
2021-01-06
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine

Interventions

medical treatment
Hyperbaric oxygen therapy

Sponsors

Amir N Wadee
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1- patients with type 2 diabetes since < 10 years of both genders ( 2- both genders were included 3- with ages ranged from (40-65 years) 4- all patients had controlled blood glucose levels all over the whole duration of the study in which (HbA1C <48 mmol/mol). 5- All Patients had Cardiac Ejection Fraction (CEF) = 50%, blood pressure (BP) = 150/90 mmHg, Chest X-ray of all patients reported normal 6- all patients were clinically evaluated by a specialized ear, nose, and thorax (ENT) physician to ensure fitting for the hyperbaric chamber.

Exclusion criteria

Exclusion criteria: Patients were excluded from the study if they had 1- chronic obstructive pulmonary disease 2- malignancy 3- cardiac pacemakers 4- any disorder that lead to pripheral neuropathy other than diabetes

Design outcomes

Primary

MeasureTime frame
Nerve conduction studies including latency, amplitude, and velocity.

Secondary

MeasureTime frame
Michigan Neuropathy Screening Instrument

Countries

Egypt

Contacts

Public ContactSeham Fahmy

PhD in Physical Therapy for Surgery and Head of HBO and Foot Care Center at Kobri El koba military hospital

fahmysiham@gmail.com01272346919

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026